Bumper Offer - Urjas oil Just @ Rs. 1 X
Romilast 5 Mg Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Asthma, Allergic Rhinitis. Other than this, Romilast 5 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Romilast 5 Mg Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Romilast 5 Mg Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Romilast 5 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Romilast 5 Mg Tablet's effect during pregnancy is Moderate and Moderate while nursing. In addition, Romilast 5 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Romilast 5 Mg Tablet related warnings section.
Other contraindications of Romilast 5 Mg Tablet have been discussed in the sections ahead.
Besides this, Romilast 5 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Romilast 5 Mg Tablet, it is important to know that it is safe while driving, and is habit-forming.
Romilast 5 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Romilast 5 Mg Tablet is used -
Severe
Moderate
Mild
Is the use of Romilast 5 Mg Tablet safe for pregnant women?
Romilast may have some side effects during pregnancy. Pregnant women should discontinue the use of Romilast, and talk to their doctor, if they notice any discomfort.
Is the use of Romilast 5 Mg Tablet safe during breastfeeding?
Romilast can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Romilast 5 Mg Tablet on the Kidneys?
Romilast has very mild side effects on the kidneys.
What is the effect of Romilast 5 Mg Tablet on the Liver?
There may be an adverse effect on the liver after taking Romilast. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Romilast 5 Mg Tablet on the Heart?
Romilast has very mild side effects on the heart.
Romilast 5 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Romilast 5 Mg Tablet unless your doctor advises you to do so -
Is this Romilast 5 Mg Tablet habit forming or addictive?
Romilast 5 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Romilast 5 Mg Tablet does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Romilast 5 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Romilast 5 Mg Tablet for mental disorders.
Interaction between Food and Romilast 5 Mg Tablet
Due to the absence of research, it is difficult to say how Romilast 5 Mg Tablet and food will interact.
Interaction between Alcohol and Romilast 5 Mg Tablet
Consuming Romilast 5 Mg Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)